178 related articles for article (PubMed ID: 22469609)
1. Local sclerotherapy with polydocanol (Aethoxysklerol®) for the treatment of Epistaxis in Rendu-Osler-Weber or Hereditary Hemorrhagic Telangiectasia (HHT): 15 years of experience.
Morais D; Millás T; Zarrabeitia R; Botella LM; Almaraz A
Rhinology; 2012 Mar; 50(1):80-6. PubMed ID: 22469609
[TBL] [Abstract][Full Text] [Related]
2. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
3. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).
Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM
Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912
[TBL] [Abstract][Full Text] [Related]
4. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.
Boyer H; Fernandes P; Le C; Yueh B
Int Forum Allergy Rhinol; 2015 May; 5(5):435-40. PubMed ID: 25643928
[TBL] [Abstract][Full Text] [Related]
6. [Local sclerosing treatment with etoxiesclerol in ORL disease: Rendu-Osler disease, granuloma, angioma...].
Morais D; Ramírez B; Santos J
Acta Otorrinolaringol Esp; 2002 Nov; 53(9):658-61. PubMed ID: 12584880
[TBL] [Abstract][Full Text] [Related]
7. Osler-Weber-Rendu Syndrome in Relation to Dermatology.
Orizaga-Y-Quiroga TL; Villarreal-Martínez A; Jaramillo-Moreno G; Ocampo-Candiani J
Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):526-532. PubMed ID: 30975431
[TBL] [Abstract][Full Text] [Related]
8. Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study.
Boyer H; Fernandes P; Duran O; Hunter D; Goding G
Int Forum Allergy Rhinol; 2011; 1(4):319-23. PubMed ID: 22287439
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
[TBL] [Abstract][Full Text] [Related]
10. Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).
Vaiman M; Martinovich U; Eviatar E; Kessler A; Segal S
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):359-63. PubMed ID: 15166924
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
12. Telangiectasias, recurrent epistaxis and a strong family history-a case of Osler- Weber-Rendu Syndrome in Pakistan.
Arif Siddiqui MM; Hafeez T; Din RU
J Pak Med Assoc; 2024 Apr; 74(4):800-803. PubMed ID: 38751284
[TBL] [Abstract][Full Text] [Related]
13. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
[TBL] [Abstract][Full Text] [Related]
14. Oral vascular malformation in a patient with hereditary hemorrhagic telangiectasia: a case report.
Hopp RN; de Siqueira DC; Sena-Filho M; Jorge J
Spec Care Dentist; 2012; 32(1):11-4. PubMed ID: 22229593
[TBL] [Abstract][Full Text] [Related]
15. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
[TBL] [Abstract][Full Text] [Related]
16. Osler-Weber-Rendu syndrome: an anaesthetic challenge?
Chieira D; Conceição L; Semedo E; Almeida V
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27126092
[TBL] [Abstract][Full Text] [Related]
17. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
Choi JW; Joo YH; Jeong WS; Jang YJ
Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
[TBL] [Abstract][Full Text] [Related]
18. Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Thiele B; Abdel-Aty Y; Marks L; Lal D; Marino M
Ann Otol Rhinol Laryngol; 2023 Jan; 132(1):82-90. PubMed ID: 35152768
[TBL] [Abstract][Full Text] [Related]
19. Management of epistaxis in Osler-Weber-Rendu disease: recurrence of telangiectases within a nasal skin graft.
McCabe WP; Kelly AP
Plast Reconstr Surg; 1972 Aug; 50(2):114-8. PubMed ID: 4558109
[No Abstract] [Full Text] [Related]
20. Hereditary HaemorrhagicTelangiectasia--A Rare Cause of Severe Anaemia.
Deshpande P; Bhat S; Karmarkar A
J Assoc Physicians India; 2014 Dec; 62(12):48-51. PubMed ID: 26259423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
